Clinical Trial: Topical IL-1-Ra for Treatment of Corneal Neovascularization

Study Status: Terminated
Recruit Status: Terminated
Study Type: Interventional




Official Title: Topical IL-1-Ra for Treatment of Corneal Neovascularization

Brief Summary: The purpose of this study is to determine the effectiveness and safety of Interleukin-1-Receptor Antagonist eye drops for the treatment of corneal blood vessels.